ArticleRheumatology and therapy2025

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.

Ryuichiro Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.